This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: The Innovations of Thomas Høeg-Jensen
Introduction
Thomas Høeg-Jensen is a notable inventor based in Klampenborg, Denmark. He has made significant contributions to the field of diabetes treatment through his innovative work in insulin derivatives. With a total of 2 patents, his inventions are paving the way for advancements in pharmaceutical compositions.
Latest Patents
Høeg-Jensen's latest patents include "Peptide Extended Insulins," which are insulins connected to an amino acid oligomer that exhibit satisfactory properties. Another significant invention is the "Insulin Derivative," which relates to novel human insulin derivatives that are soluble at physiological pH values and have a prolonged profile of action. This invention also encompasses pharmaceutical compositions containing such derivatives and methods for treating diabetes and hyperglycemia.
Career Highlights
Høeg-Jensen is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to focus on developing innovative solutions for diabetes management.
Collaborations
Some of his notable coworkers include Thomas Børglum Kjeldsen and Jan Markussen, who have collaborated with him on various projects within the company.
Conclusion
Thomas Høeg-Jensen's contributions to the field of diabetes treatment through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the lives of many individuals living with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile